Provided by Tiger Trade Technology Pte. Ltd.

Exact Sciences

103.43
+0.03500.03%
Volume:1.48M
Turnover:153.49M
Market Cap:19.73B
PE:-93.85
High:103.67
Open:103.60
Low:103.38
Close:103.39
52wk High:103.67
52wk Low:38.81
Shares:190.81M
Float Shares:187.46M
Volume Ratio:0.81
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1021
EPS(LYR):-1.1021
ROE:-8.66%
ROA:-1.59%
PB:8.22
PE(LYR):-93.85

Loading ...

Abbott Laboratories Said to Near Deal to Acquire Exact Sciences, Bloomberg Reports

MT Newswires Live
·
Nov 20, 2025

Abbott near deal to buy Exact Sciences, Bloomberg says

TIPRANKS
·
Nov 20, 2025

Exact Sciences jumps 14%, halted after Bloomberg report on takeover talks

TIPRANKS
·
Nov 20, 2025

Exact Sciences Q3 Basic EPS USD -0.1

Reuters
·
Nov 20, 2025

Freenome Announces Exclusive Agreement With Roche To Expand Technology Collaboration, Develop And Commercialize Cancer Screening Tests Outside U.S.

Reuters
·
Nov 18, 2025

Cathie Wood Raises Bets on Alibaba and Baidu; Cuts RDDT, EXAS, and IRDM

TIPRANKS
·
Nov 12, 2025

Exact Sciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Nov 12, 2025

Exact Sciences notes expiration of HSR waiting period for Freenome license pact

TIPRANKS
·
Nov 10, 2025

Exact Sciences backs FY25 revenue view $3.22B-$3.24B, consensus $3.23B

TIPRANKS
·
Nov 10, 2025

BRIEF-Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome's Blood-Based Colorectal Cancer Screening Tests

Reuters
·
Nov 10, 2025

Exact Sciences price target raised to $85 from $65 at Citi

TIPRANKS
·
Nov 10, 2025

A Look at Exact Sciences (EXAS) Valuation Following Record Q3 Results and Raised Guidance

Simply Wall St.
·
Nov 08, 2025

Exact Sciences Shares Down 2.9% Premarket After Co Announces Results From Liver Cancer Detection Study

THOMSON REUTERS
·
Nov 07, 2025

Exact Sciences Unveils Blood Test Showing Superior Early Detection of Liver Cancer in Landmark Study

Reuters
·
Nov 07, 2025

Exact Sciences Corp - Oncoguard Liver Test Shows 82% Specificity in Altus Study

THOMSON REUTERS
·
Nov 07, 2025

Exact Sciences Announces Breakthrough Results From Landmark Study Demonstrating Superior Early Detection of Liver Cancer With Blood-Based Surveillance Test

THOMSON REUTERS
·
Nov 07, 2025

EXACT Sciences SVP and General Counsel James Herriott Reports Sale of Common Shares

Reuters
·
Nov 07, 2025

EXACT Sciences EVP Brian Baranick Reports Sale of Common Shares

Reuters
·
Nov 07, 2025

Exact Sciences Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Nov 05, 2025

Exact Sciences Corp. : Wells Fargo Raises Target Price to $85 From $68

THOMSON REUTERS
·
Nov 05, 2025